Three Myths About Tort Reform

Tort reform has sullied the political landscape of this country for years.  A set of proposed laws and regulations at both the state and federal level, one central aim of tort reform is to limit the compensation an injured party can recover in a personal injury lawsuit, or “tort,” attempting to “save” health care from


Case Report: Cymbalta Withdrawal Persists for 10 Months

In January, 2014, an article published in The Journal of Neuropsychiatry and Clinical Neurosciences titled “Long-Term Duloxetine Withdrawal Syndrome and Management in a Depressed Patient” reported on a depressed patient who used Cymbalta (duloxetine), discontinued the drug, and faced long-term withdrawal symptoms. After using Cymbalta (60mg/day) for one year, the patient, called “Miss B” in


Xarelto Lawsuit Information

WARNING: Xarelto Linked to Fatal Internal Bleeding, No Reversal Agent Recently, the anticoagulant drug Xarelto (rivaroxaban) has come under increased scrutiny by both the United States Food and Drug Administration and medical professionals alike, citing an increased risk for internal bleeding.  Unfortunately, there is as yet no reversal agent for the drug. Due to inadequate




Surgical Removals of Mirena IUD Increasing

A number of lawsuits have arisen due to the complications caused by the use of intrauterine contraceptive devices (IUDs).  It has been shown that with the increase in popularity of IUDs, there has been a notable rise of cases where migration of the devices leads to a need for corrective surgery for the removal of


From Conservative Court to Activist Court in One Decision

When is a conservative court not a conservative court?  When it expands tort liability, apparently: Last month, in Wyeth v. Weeks, the Alabama Supreme Court adopted an aggressive new theory of tort liability that threatens to return Alabama to a litigation era so hostile to business and industry that the state was dubbed “Tort Hell.” In Weeks,



colorado judge dismisses case against hospital; forgets to disclose that his brother is an executive there

What’s that?  I think it’s the appearance of impropriety: "I understand (the plaintiff’s attorneys) would be stunned and upset," Munch said. "I have made disclosures in cases. I certainly should have disclosed it." Rebecca Aviel, a legal ethics professor at the University of Denver, said it’s clear Munch had a responsibility to inform attorneys in


Asbestos, tobacco, and now tanning salons?

The first thing any industry faced with negative scientific evidence does is form a trade group.  And the first thing that trade group does is gin up “scientific” evidence that claims the industry is being falsely maligned.  The asbestos industry did (and does) it, and of course so did the tobacco industry.  Now, it’s the